Incordex CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink

17 Jan 2025

ICDX

Incordex CORP

8-K: Incordex Corp. Announces Change in Control and Executive Leadership Following Share Sale

Incordex Corp. sees a complete overhaul of its leadership as CEO Iurii Abramovici sells his 5,000,000 shares to Jun Lu, who will take over as CEO, CFO, President, Secretary, and Director.

OTC.Pink

14 Aug 2024

ICDX

Incordex CORP

8-K: Incordex Corp. Announces Change in Independent Accounting Firm

Incordex Corp. has replaced its independent accounting firm, with FRUCI & ASSOCIATES II, PLLC resigning and Boladale Lawal and Co, Chartered Accountants being appointed.